Zum Hauptinhalt springen
Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Biochemistry of Drug Metabolizing Enzymes -

Biochemistry of Drug Metabolizing Enzymes

Trends and Challenges
Buch | Softcover
586 Seiten
2022
Academic Press Inc (Verlag)
978-0-323-95120-3 (ISBN)
CHF 235,65 inkl. MwSt
  • Versand in 15-20 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
Biochemistry of Drug Metabolizing Enzymes: Trends and Challenges is a complete and well-integrated reference on their mechanisms of action, their role in diseases, agents responsible for their deactivation, and their malfunction. Chapters explain the biochemistry of DMEs, including biochemical activation, functions, computational approaches, different contaminants on the action and function of DMEs, and describe the importance of DMEs in the drug development process. Conditions covered include metabolic diseases, cardiovascular diseases, neurological diseases, physiological diseases, xenobiotics and inflammatory responses, and their contribution in the malfunctioning of drug metabolizing enzymes.

This book is the perfect resource for pharmacology and biochemistry researchers to understand the principles of DMEs. Researchers in the corporate environment will also benefit from the comprehensive list of diseases associated with malfunction of DMEs.

Dr. Akash is currently working as an Associate Professor at the Department of Pharmaceutical Chemistry, Government College University Faisalabad, Pakistan. He got his PhD degree in Pharmaceutical Analysis from Zhejiang University, China. Currently, he is focusing on investigating the effect of endocrine disrupting chemicals on various molecular and metabolic pathways that are involved in metabolic disorders and their treatment strategies. His research work is cutting-edge and worthy of extension in developing countries, like Pakistan, where it can be most beneficial and cost-effective, especially for diabetic patients. Based on his significant scientific contributions in the field of Pharmaceutical Sciences, he has been awarded “Research Productivity Awards” from the Pakistan Council for Science and Technology, the PAS Gold Medal from the Pakistan Academy of Sciences, and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan. Dr. Kanwal Rehman is working as an Associate Professor at the Department of Pharmacy in The Women University, Multan, Pakistan. Dr. Rehman received her PhD in Pharmacology from Zhejiang University, China. She nurtures a keen interest in the pathogenesis of metabolic disorders and new therapeutic modalities for its treatment. Currently, she is focusing on the investigation of the role of pharmacogenomics based upon gene polymorphism on various molecular and metabolic pathways that are involved in mitogenic disorders and treatment strategies, like natural biogenic compounds against different risk factors of metabolic disorders, including pancreatitis, cardiometabolic disorders, and hormonal imbalance. Dr. Rehman has also been awarded the Research Productivity Award by the Pakistan Council for Science and Technology, Pakistan; the PAS Gold Medal from the Pakistan Academy of Sciences; and the A.R. Shakoori Gold Medal from the Zoological Society of Pakistan.

1. Biochemical activation of drug metabolizing enzymes: From mechanism of action to functions
2. Computational approaches and drug metabolizing enzymes: Concepts and challenges
3. Biotransformation of drugs by drug metabolizing enzymes: Concepts and challenges
4. Emerging environmental contaminants and drug metabolizing enzymes: Retrospective analysis and prospects
5. Impact of prodrugs on drug metabolizing enzymes: From function to regulation
6. Impact of hormones on drug metabolizing enzymes: From function to regulation
7. Impact of receptors on drug metabolizing enzymes: From function to regulation
8. Biochemistry of cathepsin enzymes and metabolic functions in lysosome
9. Fate of drug metabolizing enzymes in metabolic diseases: Challenges and strategies
10. Fate of drug metabolizing enzymes in cardiovascular diseases: Challenges and strategies
11. Fate of drug metabolizing enzymes in neurological diseases: Challenges and strategies
12. Impact of physiological factors on drug metabolizing enzymes: Challenges and strategies
13. Xenobiotics and drug metabolizing enzymes: Challenges and strategies
14. Drug metabolizing enzymes and inflammatory responses: Mechanism of induction and treatment strategies
15. Polymorphism and drug metabolizing enzymes: Challenges and strategies
16. Modulation of human microbiome and drug metabolism: Current trends and future prospects
17. Bioanalytical techniques for prediction of metabolic activity of drug metabolizing enzymes: Challenges
18. Role of pharmacogenomics for prediction of personalized medicines: Concepts and challenges
19. Dietary sources of drug metabolizing enzymes: From production to regulation
20. Vitamin deficiencies and drug metabolizing enzymes: Challenges and strategies
21. Malnutrition and Drug metabolizing enzymes: Challenges and strategies
22. Drug metabolizing enzymes and oxidative stress: Mechanism of induction and treatment strategies

Erscheinungsdatum
Verlagsort Oxford
Sprache englisch
Maße 191 x 235 mm
Gewicht 1200 g
Themenwelt Medizin / Pharmazie Medizinische Fachgebiete Pharmakologie / Pharmakotherapie
ISBN-10 0-323-95120-1 / 0323951201
ISBN-13 978-0-323-95120-3 / 9780323951203
Zustand Neuware
Informationen gemäß Produktsicherheitsverordnung (GPSR)
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich